Financials
- Market Capitalization 442.67 M
- Employee 22
- Founded 2017
- CEO N/A
- Website www.q32bio.com
- Headquarter Delaware, United States
- FIGI BBG00CTTJWQ9
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
4.08
Relación precio/flujo de caja
120.41
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2786 | CBIO Crescent Biopharma, Inc. - Common Stock | 16.60 USD | -6.48% | -3.04% | +12.01% | +14.56% | 616.59 M USD | ||
| 2852 | EIKN Eikon Therapeutics, Inc. - Common Stock | 10.46 USD | -4.74% | -7.10% | +11.51% | -38.65% | 566.57 M USD | ||
| 3153 | UPB Upstream Bio, Inc. - Common Stock | 6.62 USD | -1.05% | -0.90% | +4.91% | -60.26% | 362.58 M USD | ||
| 3334 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 13.88 USD | -0.64% | -0.29% | -2.80% | -10.80% | 293.18 M USD |